<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>VentureBeat - Latest Comments in Life-science briefing: Tuesday, April 1, 2008</title><link>http://venturebeat.disqus.com/</link><description>News about Tech, Business and Innovation</description><atom:link href="https://venturebeat.disqus.com/life_science_briefing_tuesday_april_1_2008/latest.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Wed, 02 Apr 2008 00:25:16 -0000</lastBuildDate><item><title>Re: Life-science briefing: Tuesday, April 1, 2008</title><link>http://venturebeat.com/2008/04/01/life-science-briefing-tuesday-april-1-2008/#comment-14684191</link><description>&lt;p&gt;Enormous Market Potential for Alure Medical Inc.&lt;br&gt;Minimally invasive plastic surgery and aesthetics market is exploding. For ALure Medical products the regulatory pathway can be as quick as a 510 K approval from the agency, which will enable Alure to market their unique line of products like the minimally-invasive ‘lunch time lift’ as a revolutionary alternative to current surgical mastopexy procedures for breast sagging and other products for neck line sagging. &lt;br&gt;Congratulations to Alure team.&lt;/p&gt;&lt;p&gt;Raj Nihalani, MD, RAC(US)&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raj Nihalani, MD, RAC(US)</dc:creator><pubDate>Wed, 02 Apr 2008 00:25:16 -0000</pubDate></item></channel></rss>